Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

NCT05684692 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Schwannomatosis
Schwannomas
Pain, Chronic

Interventions

DRUG: Siltuximab
DRUG: Erenumab-Aooe
DRUG: Siltuximab Matching Placebo
DRUG: Erenumab-Aooe Matching Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]